Joshua Phillips is a Founder and Managing Partner of Catalyst Health Ventures. He has led investments in the medical device, life science tools, molecular diagnostics, and biopharma markets holding fourteen board seats, including a leading role in six M&A exits. Josh is currently a Director at Conformal Medical, Brixton Biosciences, Sera Prognostics, Saphena Medical, and Cruzar Medsystems.
Prior to Catalyst, Josh was a Manager at the Lucas Group, a boutique strategy consulting firm, where he led engagements advising healthcare, life science, and technology-based companies. Prior to entering business school, he co-founded and built a new business unit at Russelectric Inc, a privately held company producing power control systems. During his five-year tenure, revenue grew to $5M and headcount expanded to 15 engineers and technicians. Previously Josh held a project management position at Pratt & Whitney Aircraft focused on control system hardware/software integration for the world’s first fly-by-wire jet engine, now powering the USAF F-22 Raptor.
Josh received his B.E. in Electrical Engineering and Mathematics from Vanderbilt University and an M.B.A. from the Harvard School of Business Administration.